Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 4CNS 1

Conditions

Sarcoma 2Glioblastoma 2Sarcoma, Ewing 1Rhabdomyosarcoma 1Pancreatic Neoplasms 1Osteosarcoma 1Neuroblastoma 1Neoplasms 1Neoplasm Metastasis 1Lymphoma, Non-Hodgkin 1Lung Neoplasms 1Leukemia-Lymphoma, Adult T-Cell 1Kidney Neoplasms 1Hereditary Sensory and Autonomic Neuropathies 1Gliosarcoma 1Glioma 1Desmoid Tumors 1Colorectal Neoplasms 1Breast Neoplasms 1Bone Neoplasms 1

Interventions

Cyclophosphamide 8Temozolomide 6Topotecan 5Melphalan 5Granulocyte Colony-Stimulating Factor 5X-Rays 4Phantoms, Imaging 4Irinotecan 4palbociclib 3fludarabine 3Vincristine 3Specimen Handling 3Sirolimus 3Magnetic Resonance Spectroscopy 3Busulfan 3Bone Marrow Transplantation 3ulixertinib 2tipifarnib 2tazemetostat 2selpercatinib 2ivosidenib 2irinotecan sucrosofate 2cabozantinib 2abemaciclib 2Zoledronic Acid 2Vemurafenib 2Nuclear Medicine Department, Hospital 2Nivolumab 2Mesna 2LY3023414 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Sarcoma, Ewing × liposomal doxorubicin × CNS × Clear all
NCT02557854 2019-03-19

HIFU Hyperthermia With Liposomal Doxorubicin (DOXIL) for Relapsed or Refractory Pediatric and Young Adult Solid Tumors

University of Texas Southwestern Medical Center

Phase 1 Withdrawn
CNSSarcoma

Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Osteosarcoma, Desmoid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡